Life Sciences & Biotechnology
Research Agricultural
Total number of Record(s): 5828
| Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
|---|---|---|---|---|
| Development of an endogenous STING agonist adjuvanted mycobacterium bovis BCG vaccine to enhance efficacy against tuberculosis | Dr. R.J. Dey Assistant Professor Birla Institute of Technology & Science (Pilani ) Telangana | 2020 | Department of Bio-Technology (DBT) | Research & Development (R&D) |
| Development of anti-viral peptide aptamers for SARS-Cov-2- Design & evaluation | Dr. K.M.P. Raja Assistant Professor Central University of Kerala Kerala | 2020 | Department of Bio-Technology (DBT) | Research & Development (R&D) |
| DNA repair in giant viruses- Biochemical insights into the first virus-coded putative base excision repair pathway | Prof. K. Kondabagil Associate Professor Indian Institute of Technology (Bombay), Maharshtra Maharashtra | 2020 | Department of Bio-Technology (DBT) | Research & Development (R&D) |
| Heparinoids based adjuvants for flaviviruses vaccine development | Dr. R. Kikkeri Associate Professor Indian Institute of Science, Bangalore, Karnataka Education & Research (Pune) Maharashtra | 2020 | Department of Bio-Technology (DBT) | Research & Development (R&D) |
| High-affinity binders against COVID-19 spike protein using display libraries | Dr. M. Sirajuddin Institute of Stem Cell Biology & Regenerative Medicine Karnataka | 2020 | Department of Bio-Technology (DBT) | Research & Development (R&D) |
| Identifying therapeutic targets for blocking infection of highly pathogenic SARS-CoV-2 at an early stage- Developing novel screening assay with minimal bio-hazard risk | Dr. A. Krishnan Assistant Professor Jamia Hamdard Delhi | 2020 | Department of Bio-Technology (DBT) | Research & Development (R&D) |
| Inhibition of interaction between receptor binding domain of spike protein of SARS-CoV-2 & human ACE2 by protein mimic DNA [BT/TEMP10623/COVID/02/20] | Dr. R.N. Karanam Associate Professor Indian Institute of Technology (Hyderabad) Telangana | 2020 | Department of Bio-Technology (DBT) | Research & Development (R&D) |
| Investigating SARS-CoV2 3-5 exonuclease (NSP14/ExoN) as therapeutic target for CoVID19 | Dr. V.T. Natarajan Principal Scientist CSIR-Institute of Genomics & Integrative Biology Delhi | 2020 | Department of Bio-Technology (DBT) | Research & Development (R&D) |
| Pre-clinical evaluation of combination adjuvants for humoral & T cell immunity to respiratory Syncytial virus | Prof. G.R. Medigeshi Translational Health Science & Technology Institute Haryana | 2020 | Department of Bio-Technology (DBT) | Research & Development (R&D) |
| Synthesis & anti-viral evaluation of newly designed nucleoside analogs beyond repurposing through revamping against emerging Coronavirus 2019 nCoV/SARS-CoV-2 by computational protocols | Dr. K.H. Harshan Principal Scientist CSIR-Centre for Cellular & Molecular Biology Telangana | 2020 | Department of Bio-Technology (DBT) | Research & Development (R&D) |